Global /India /Healthcare /Drug Manufacturers - General /MOREPENLAB
chevron_leftBack
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd.

MOREPENLAB
NSE: MOREPENLAB Delayed
41.36INR -1%
0.4381 USD
As of 20 June 2026, Morepen Laboratories Ltd. has a market cap of $242.73M USD, ranking #19887 globally and #1130 in India. It ranks #1786 in the Healthcare sector, and #650 in the Drug Manufacturers - General industry.
Global Rank
19887
Country Rank
1130
Sector Rank
1786
Industry Rank
650
Key Stats
Market Cap
$242.73MUSD
22.91B INR
Enterprise Value
$250.94MUSD
23.69B INR
Revenue (TTM)
$189.31MUSD
17.87B INR
EBITDA (TTM)
$10.66MUSD
1.01B INR
Net Income (TTM)
$10.54MUSD
994.48M INR
EBITDA Margin
5.6%
Profit Margin
5.6%
PE Ratio
23.0
PS Ratio
1.3
PB Ratio
1.9
EV/EBITDA
21.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Sushil Suri open_in_new
Employees
1,814
Founded
1984
Website
morepen.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1% -0.1% 16% 17% -14% -33%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
MOREPENLAB
Morepen Laboratories Ltd
ISIN: INE083A01026
Shares Out.:
547.954M1 Shares Float: 314.262M2
TV:
SA:
YF:
GF:
BA:
MS:
41.36 INR
Bombay Stock Exchange
MIC: XBOM
500288 (MOREPENLAB)
Morepen Laboratories Ltd
ISIN: INE083A01026
TV:
SA:
YF:
GF:
BA:
MS:
41.81 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Morepen Laboratories Ltd.

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
19K%
39.1
DIVISLAB
$18.38B
1.73T INR
7K%
70.0
$15.17B
1.43T INR
6K%
63.0
$11.73B
1.11T INR
5K%
19.6
MANKIND
$9.87B
931.67B INR
4K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
4K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
314K%
38.1
JNJ
$547.28B
225K%
26.4
ABBV
$360.63B
148K%
97.4
$318.3B
256.25B CHF
131K%
19.9
AZN
$284.64B
215.59B GBP
117K%
27.6
MRK
$274.03B
113K%
15.1
chevron_leftBack